Angel One - Share Market Trading and Stock Broking
LoginOpen Demat Account
Skip to main content
Xeris Biopharma Holdings, Inc. Common Stock logo

Xeris Biopharma Holdings, Inc. Common Stock Share Price

NASDAQ: XERSHealthcare

$10.46

+0.33 (3.26%)
BUYSELL

Live Xeris Biopharma Holdings, Inc. Common Stock Share Price Chart

O H L

Xeris Biopharma Holdings, Inc. Common Stock Performance Overview

Days Range
▼
$10.09Low
$10.60High

Markets Today

Previous Close$10.19
Open$10.13
Volume2,702,787
Day's Range$10.09 - $10.60
52W Range$5.25 - $11.33
Market Cap$1.86 B

Historical Performance

1M Returns+36.64
3M Returns+25.66
6M Returns+79.15
1Y Returns+31.16
5Y Returns+411.22
10Y ReturnsNA

Xeris Biopharma Holdings, Inc. Common Stock Fundamentals

Market Cap$1.86 B
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$291.85 M
ROE TTMN/A
EPS TTM$-0.11
Quarterly Earnings Growth YOYN/A
PB RatioN/A
EBITDA$37.05 M
Profit Margin0.19
Market Cap$1.86 B
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$291.85 M
ROE TTMN/A
EPS TTM$-0.11
Quarterly Earnings Growth YOYN/A
PB RatioN/A
EBITDA$37.05 M
Profit Margin0.19

Xeris Biopharma Holdings, Inc. Common Stock Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$60.12 M$71.54 M$74.38 M$85.81 M$83.13 M$92.10 M
Gross Profit +$51.39 M$59.64 M$63.38 M$74.86 M$72.55 M$79.59 M
Operating Income -$3.09 M$4.48 M$6.73 M$16.77 M$7.92 M$5.17 M
EBITDA -$65.00 K$7.52 M$9.78 M$19.82 M$10.96 M$8.21 M
Interest Expense -$7.30 M-$7.36 M-$7.27 M-$7.15 M-$6.88 M-$6.95 M
Depreciation $3.02 M$3.04 M$3.05 M$3.05 M$3.05 M$3.03 M
Income Before Tax -$9.22 M-$1.93 M$621.00 K$11.08 M$2.23 M-$31.10 M
Income Tax Expense $0$0$0$0$0$0
Net Income +-$9.22 M-$1.93 M$621.00 K$11.08 M$2.23 M-$31.10 M
Net Profit Margin -15.34%-2.7%0.83%12.91%2.69%-33.77%

Xeris Biopharma Holdings, Inc. Common Stock Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $16.00 K$16.00 K$17.00 K$17.00 K$18.00 K$18.00 K
Reserve & Surplus -$681.11 M-$683.03 M-$682.41 M-$671.33 M-$669.10 M-$700.18 M
Non-Current Liabilities $255.51 M$258.82 M$254.85 M$260.26 M$260.41 M$232.07 M
Current Liabilities $95.07 M$95.17 M$116.20 M$109.57 M$118.59 M$189.57 M
Total Liabilities $350.58 M$353.99 M$371.05 M$369.84 M$379.00 M$421.64 M
Fixed Assets $101.47 M$98.78 M$95.73 M$93.02 M$90.40 M$87.49 M
Current Assets $163.49 M$185.58 M$224.02 M$240.31 M$251.68 M$274.76 M
Total Assets $315.45 M$334.69 M$370.19 M$383.53 M$392.01 M$411.90 M

Xeris Biopharma Holdings, Inc. Common Stock Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$9.22 M-$1.93 M$621.00 K$11.08 M$2.23 M-$31.10 M
Operating Cash Flow -$10.03 M$182.00 K$18.43 M$20.04 M$9.87 M$8.26 M
Investing Cash Flow -$13.00 K-$279.00 K-$71.00 K-$333.00 K-$325.00 K-$209.00 K
Financing Cash Flow -$3.14 M$942.00 K$13.85 M-$266.00 K-$8.84 M$1.94 M
Change in Cash -$13.18 M$845.00 K$32.21 M$19.44 M$708.00 K$10.00 M

Xeris Biopharma Holdings, Inc. Common Stock Return Calculator

The Xeris Biopharma Holdings, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$51,024
Invested Amount$10,000
Est. Returns$41,024
Invest in USA Stock Today

About Xeris Biopharma Holdings, Inc. Common Stock

Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offers Recorlev for the treatment of endogenous hypercortisolemia in patients with Cushing's syndrome; Gvoke for the treatment of severe hypoglycemia; and Keveyis for the treatment of Primary Periodic Paralysis (PPP). Additionally, the company is advancing its Phase 3-ready pipeline product, XP-8121, a once-weekly subcutaneous injection of levothyroxine, which leverages its proprietary technology, XeriSol.

FAQs

Xeris Biopharma Holdings, Inc. Common Stock (XERS) share price as of October 10, 2026 is $10.46. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Xeris Biopharma Holdings, Inc. Common Stock (XERS) Share by opening an international trading account with Angel One.
Purchasing Xeris Biopharma Holdings, Inc. Common Stock (XERS) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Xeris Biopharma Holdings, Inc. Common Stock (XERS) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Xeris Biopharma Holdings, Inc. Common Stock (XERS) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Xeris Biopharma Holdings, Inc. Common Stock on October 10, 2026, is $1.86 B.
Xeris Biopharma Holdings, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Xeris Biopharma Holdings, Inc. Common Stock (XERS) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Want to open an NRI account?
Top US Stocks

VIEW ALL